German drugmaker Merck KGaA said on Thursday ‌it would buy U.S. firm Bio-Techne for $11.3 billion, its biggest deal in more ...

By Deena Beasley June 30 (Reuters) - The chair of the U.S. House Select Committee on China opened national security ...

RAHWAY, N.J. and FOSTER CITY, Calif., March 25, 2026 (GLOBE NEWSWIRE) -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Terns Pharmaceuticals, Inc. (“Terns”) (Nasdaq: ...

Germany’s Merck KGaA has announced a major acquisition agreement to buy U.S.-based life sciences company Bio-Techne Corp ...

Rahway-based pharma giant Merck finalized its $6.7 billion acquisition of Terns Pharmaceuticals. When the deal closed May 5, the California-headquartered oncology company became a wholly owned ...

With pharma heavyweights clashing against one another and reeling in major sales in the ulcerative colitis (UC) | Merck is ...

German pharma giant Merck has inked a deal to acquire US life sciences company Bio-Techne for $11.3 billion to expand its ...

Merck stock has shown some solid short-term strength, with its stock price of $98.90 comfortably sitting above its eight-day and 20-day simple moving averages (SMAs) of $97.81 and $98.64, respectively ...

Johnson & Johnson is a global leader in the pharmaceutical and medical device industries. Its key products include ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Terns Pharmaceuticals, Inc. (“Terns”) (Nasdaq: TERN), a clinical-stage oncology company, today announced that the companies ...